Try our beta test site
83 studies found for:    apatinib
Show Display Options
Rank Status Study
1 Completed Effect of Rifampicin on the Pharmacokinetics of Apatinib
Condition: Neoplasms
Interventions: Drug: Apatinib Mesylate Tablets;   Drug: Rifampicin Capsules
2 Not yet recruiting Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)
Condition: Small Cell Lung Cancer
Intervention: Drug: Apatinib Mesylate tablet
3 Not yet recruiting A Phase II Study of Apatinib in STS Patients
Condition: Soft Tissue Sarcoma
Intervention: Drug: apatinib
4 Recruiting Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients
Condition: Colorectal Neoplasms
Intervention: Drug: Apatinib and XELOX combined treatment group
5 Recruiting Apatinib for Metastatic Esophageal Cancer.
Conditions: Esophageal Cancer;   Metastatic Esophageal Cancer;   Apatinib
Intervention: Drug: Apatinib
6 Not yet recruiting A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure
Condition: Hepatocellular Carcinoma
Intervention: Drug: Apatinib Mesylate Tablets
7 Recruiting The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: apatinib single agent
8 Recruiting Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Apatinib single agent arm
9 Recruiting Apatinib as Second-line Treatment of Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: Apatinib
10 Recruiting Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: Apatinib
11 Completed Effect of Itraconazole on the Pharmacokinetics of Apatinib
Condition: Neoplasms
Interventions: Drug: Apatinib Mesylate Tablets;   Drug: Itraconazole Capsules
12 Not yet recruiting A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: SHR-1210;   Drug: Apatinib
13 Recruiting Apatinib for Advanced Non-squamous Head and Neck Cancer
Condition: Head and Neck Neoplasms
Intervention: Drug: Apatinib
14 Active, not recruiting The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Biological: Cytokine-Induced Killer Cells;   Drug: Apatinib
15 Active, not recruiting The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR
Condition: Adenocarcinoma of Lung
Interventions: Biological: Cytokine-Induced Killer Cells;   Drug: Apatinib
16 Completed A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: Apatinib
17 Active, not recruiting Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Apatinib
18 Recruiting The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Apatinib;   Drug: Oxaliplatin;   Drug: S-1
19 Recruiting Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: apatinib
20 Recruiting Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
Conditions: Osteosarcoma;   Metastasis
Intervention: Drug: apatinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.